Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2009 1
2010 4
2011 4
2012 3
2014 4
2015 4
2016 5
2017 10
2018 3
2019 3
2020 2
2021 3
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.
Gianni L, Eiermann W, Semiglazov V, Manikhas A, Lluch A, Tjulandin S, Zambetti M, Vazquez F, Byakhow M, Lichinitser M, Climent MA, Ciruelos E, Ojeda B, Mansutti M, Bozhok A, Baronio R, Feyereislova A, Barton C, Valagussa P, Baselga J. Gianni L, et al. Among authors: climent ma. Lancet. 2010 Jan 30;375(9712):377-84. doi: 10.1016/S0140-6736(09)61964-4. Lancet. 2010. PMID: 20113825 Clinical Trial.
Sorafenib in renal cell carcinoma.
Arranz JÁ, Climent MÁ, González-Larriba JL, León L, Maroto JP. Arranz JÁ, et al. Among authors: climent ma. Crit Rev Oncol Hematol. 2011 Nov;80(2):314-22. doi: 10.1016/j.critrevonc.2011.01.008. Epub 2011 Mar 21. Crit Rev Oncol Hematol. 2011. PMID: 21419641 Review.
Recent therapeutic advances in urothelial carcinoma: A paradigm shift in disease management.
Bellmunt J, Valderrama BP, Puente J, Grande E, Bolós MV, Lainez N, Vázquez S, Maroto P, Climent MÁ, Garcia Del Muro X, Arranz JÁ, Durán I. Bellmunt J, et al. Among authors: climent ma. Crit Rev Oncol Hematol. 2022 Jun;174:103683. doi: 10.1016/j.critrevonc.2022.103683. Epub 2022 Apr 16. Crit Rev Oncol Hematol. 2022. PMID: 35439541 Free article. Review.
Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting.
Garrido Siles M, López-Beltran A, Pelechano P, García Vicente AM, Gironés Sarrió R, González-Haba Peña E, Rodríguez Antolín A, Zapatero A, Arranz JÁ, Climent MÁ; Spanish Oncology Genitourinary Multidisciplinary Working Group. Garrido Siles M, et al. Among authors: climent ma. Cancers (Basel). 2022 Aug 17;14(16):3968. doi: 10.3390/cancers14163968. Cancers (Basel). 2022. PMID: 36010964 Free PMC article. Review.
Recommendations for the optimal management of early and advanced urothelial carcinoma.
Castellano D, Carles J, Esteban E, Trigo JM, Climent MÁ, Maroto JP, del Muro XG, Font A, Paz-Ares L, Arranz JÁ, Bellmunt J. Castellano D, et al. Among authors: climent ma. Cancer Treat Rev. 2012 Aug;38(5):431-41. doi: 10.1016/j.ctrv.2011.10.004. Epub 2011 Nov 23. Cancer Treat Rev. 2012. PMID: 22116017 Review.
Management of Localized Muscle-Invasive Bladder Cancer from a Multidisciplinary Perspective: Current Position of the Spanish Oncology Genitourinary (SOGUG) Working Group.
Gómez Caamaño A, García Vicente AM, Maroto P, Rodríguez Antolín A, Sanz J, Vera González MA, Climent MÁ, On Behalf Of The Spanish Oncology Genitourinary Sogug Multisiciplinary Working Group. Gómez Caamaño A, et al. Among authors: climent ma. Curr Oncol. 2021 Dec 3;28(6):5084-5100. doi: 10.3390/curroncol28060428. Curr Oncol. 2021. PMID: 34940067 Free PMC article. Review.
A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer.
Macaulay VM, Lord S, Hussain S, Maroto JP, Jones RH, Climent MÁ, Cook N, Lin CC, Wang SS, Bianchini D, Bailey M, Schlieker L, Bogenrieder T, de Bono J. Macaulay VM, et al. Among authors: climent ma. Br J Cancer. 2023 Oct;129(6):965-973. doi: 10.1038/s41416-023-02380-1. Epub 2023 Aug 3. Br J Cancer. 2023. PMID: 37537253 Free PMC article. Clinical Trial.
Management of Patients with Metastatic Bladder Cancer in the Real-World Setting from the Multidisciplinary Team: Current Opinion of the SOGUG Multidisciplinary Working Group.
González-Del-Alba A, Conde-Moreno AJ, García Vicente AM, González-Peramato P, Linares-Espinós E, Climent MÁ, The Sogug Multidisciplinary Working Group. González-Del-Alba A, et al. Among authors: climent ma. Cancers (Basel). 2022 Feb 23;14(5):1130. doi: 10.3390/cancers14051130. Cancers (Basel). 2022. PMID: 35267437 Free PMC article. Review.
51 results